2009年瑞士罗氏制药公司收购了“基因技术公司”及其忙碌的生产线。
Roche, another Swiss drug giant, bought Genentech and its busy cancer pipeline in 2009.
瑞士股市方面，罗氏制药公司股价上涨1.4%，该公司公布了一项削减成本的计划，将减少4800个工作岗位，占总岗位数的6%。
Roche rose 1.4% on the SIX Swiss Exchange after announcing cost-cutting plans that will result in the loss of around 4,800 jobs, or 6% of its workforce.
瑞士股市方面，罗氏制药公司股价上涨1.4%，该公司公布了一项削减成本的计划，将减少4800个工作岗位，占总岗位数的6%。
Roche rose 1.4% on the SIX Swiss Exchange after announcing cost-cutting plans that will result in the loss of around 4, 800 jobs, or 6% of its workforce.
越南表示，如果不能和瑞士罗氏制药公司达成生产“达菲”药品协议的话，越南可能会自行生产抗禽流感病毒的“达菲”仿制品。
Vietnam says it may produce a generic version of the antiviral drug Tamiflu if a licensing agreement cannot be reached with the drug's Swiss manufacturer (Roche Holding ag).
帕斯特纳克先生说生物仿制制药威胁到了现有的生物技术制药公司，如安进公司和基因泰克公司(现在已属瑞士制药巨头罗氏旗下)，他们的数十亿美元的销售目标现在都有风险。
Biosimilars threaten incumbent biotech firms such as Amgen and Genentech (now part of Roche, a Swiss drugs giant), which have billions of dollars of sales at risk, argues Mr Pasternak.
罗氏公司总部位于瑞士巴塞尔，在制药和诊断领域是世界领先的以研发为基础的健康事业公司。
Headquartered in Basel, Switzerl, Roche is one of the world's leading research-focused healthcare groups in the fields of pharmaceuticals diagnostics.
罗氏公司总部位于瑞士巴塞尔，在制药和诊断领域是世界领先的以研发为基础的健康事业公司。
Headquartered in Basel, Switzerl, Roche is one of the world's leading research-focused healthcare groups in the fields of pharmaceuticals diagnostics.
应用推荐